Skip to main content
Clinical Trials/IRCT201701282288N11
IRCT201701282288N11
Completed
Phase 2

Clinical trial comparing the effects of Vaccinium arctostaphylos leaf and fruit extracts with placebo on the blood levels of glycosylated hemoglobin and LDL-cholesterol and amounts of systolic and diastolic blood pressures in the hypertensive hyperlipidemic type 2 diabetic patients

Vice Chancellor for Research, ACECR Institute of Medicinal Plants0 sites150 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Diabetes mellitus.
Sponsor
Vice Chancellor for Research, ACECR Institute of Medicinal Plants
Enrollment
150
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice Chancellor for Research, ACECR Institute of Medicinal Plants

Eligibility Criteria

Inclusion Criteria

  • Iranian male and female hypertensive hyperlipidemic type 2 diabetic outpatients; patients aged 40 to 60 years; patients with blood HbA1c levels between 7% and 9%; patients with fasting blood LDL levels between 100 mg/dL and 150 mg/dL; patients with systolic blood pressures between 14 and 16 mmHg; patients with diastolic blood pressures between 9 and 10 mmHg; patients taking 15 mg glibenclamide, 2 g metformin and 20 mg atorvastatin per day; patients taking synthetic antihypertensive drugs with 3 different mechanisms per day. Exclusion criteria: Patients taking other drugs effective on the blood glucose and lipid levels; patients with cardiac, renal, hepatic, hematological diseases, hypothyroidism, tachycardia, vertigo and seizure; patients with a history of gallstones or gall bladder surgery; pregnant women; women planning pregnancy; breast\-feeding women.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials